Based on these shared features, this study was designed to evaluate whether plasma tumour M2-PK level is i) associated with disease activity and blood levels of acute phase reactants such as ESR and CRP, which are the most widely used in clinical care, and ii) higher in patients with RA than in those with osteoarthritis (OA) and controls. The gene discussed is CRP; the disease is rheumatoid arthritis.